{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T19:40:49Z","timestamp":1770234049584,"version":"3.49.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T00:00:00Z","timestamp":1582156800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T00:00:00Z","timestamp":1582156800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s10554-020-01800-0","type":"journal-article","created":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T13:03:34Z","timestamp":1582203814000},"page":"1121-1132","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Intracoronary compared with intravenous bolus tirofiban on the microvascular obstruction in patients with STEMI undergoing PCI: a cardiac MR study"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5660-8264","authenticated-orcid":false,"given":"Quanmei","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4117-0319","authenticated-orcid":false,"given":"Yue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaonan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7525-6164","authenticated-orcid":false,"given":"Tongtong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weili","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiake","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongyu","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yundi","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1608-7396","authenticated-orcid":false,"given":"Zhaoqing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9184-5441","authenticated-orcid":false,"given":"Yang","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,20]]},"reference":[{"key":"1800_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"SD Kristensen","year":"2018","unstructured":"Kristensen SD, Aboyans V (2018) 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 39:119\u2013177. https:\/\/doi.org\/10.1093\/eurheartj\/ehx393","journal-title":"Eur Heart J"},{"key":"1800_CR2","doi-asserted-by":"publisher","first-page":"787","DOI":"10.15537\/smj.2015.7.11089","volume":"36","author":"Z-X Fan","year":"2015","unstructured":"Fan Z-X, Yang J (2015) The role of microRNAs in regulating myocardial ischemia reperfusion injury. Saudi Med J 36:787\u2013793. https:\/\/doi.org\/10.15537\/smj.2015.7.11089","journal-title":"Saudi Med J"},{"key":"1800_CR3","doi-asserted-by":"publisher","first-page":"7018393","DOI":"10.1155\/2017\/7018393","volume":"2017","author":"M Neri","year":"2017","unstructured":"Neri M, Riezzo I, Pascale N, Pomara C, Turillazzi E (2017) Ischemia\/reperfusion injury following acute myocardial infarction: a critical issue for clinicians and forensic pathologists. Mediators Inflamm 2017:7018393. https:\/\/doi.org\/10.1155\/2017\/7018393","journal-title":"Mediators Inflamm"},{"key":"1800_CR4","doi-asserted-by":"publisher","first-page":"20140470","DOI":"10.1259\/bjr.20140470","volume":"88","author":"A Abbas","year":"2015","unstructured":"Abbas A, Matthews GH, Brown IW, Shambrook JS, Peebles CR, Harden SP (2015) Cardiac MR assessment of microvascular obstruction. Br J Radiol 88:20140470. https:\/\/doi.org\/10.1259\/bjr.20140470","journal-title":"Br J Radiol"},{"key":"1800_CR5","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.1093\/eurheartj\/ehx414","volume":"38","author":"S de Waha","year":"2017","unstructured":"de Waha S, Patel MR, Granger CB, Ohman EM, Maehara A, Eitel I, Ben-Yehuda O, Jenkins P, Thiele H, Stone GW (2017) Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials. Eur Heart J 38:3502\u20133510. https:\/\/doi.org\/10.1093\/eurheartj\/ehx414","journal-title":"Eur Heart J"},{"key":"1800_CR6","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.amjcard.2017.06.040","volume":"120","author":"A Elbadawi","year":"2017","unstructured":"Elbadawi A, Elgendy IY, Megaly M, Ha LD, Mahmoud K, Alotaki E, Ogunbayo GO, Baig B, Abuzaid AS, Saad M, Depta JP (2017) Meta-analysis of randomized trials of intracoronary versus intravenous glycoprotein IIb\/IIIa inhibitors in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol 120:1055\u20131061. https:\/\/doi.org\/10.1016\/j.amjcard.2017.06.040","journal-title":"Am J Cardiol"},{"key":"1800_CR7","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.ijcard.2016.07.207","volume":"222","author":"PE Puddu","year":"2016","unstructured":"Puddu PE, Iannetta L, Placanica A, Cuturello D, Schiariti M, Manfrini O (2016) The role of Glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes and the interference with anemia. Int J Cardiol 222:1091\u20131096. https:\/\/doi.org\/10.1016\/j.ijcard.2016.07.207","journal-title":"Int J Cardiol"},{"key":"1800_CR8","unstructured":"Wang HL, Xing SY, Dong PS, Han YH, Zhu JH, Lai LH, Zhao JF (2014) Safety and efficacy of intracoronary tirofiban administration in patients with serious thrombus burden and ST-elevation myocardial infarction undergoing percutaneous coronary intervention. Eur Rev Med Pharmacol Sci 18: 3690\u20133695, https:\/\/www.europeanreview.org\/article\/8172"},{"key":"1800_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ijcard.2010.08.027","volume":"153","author":"I Eitel","year":"2011","unstructured":"Eitel I, Desch S, Schindler K, Fuernau G, Schuler G, Thiele H (2011) Aborted myocardial infarction in intracoronary compared with standard intravenous abciximab administration in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction. Int J Cardiol 153:21\u201325. https:\/\/doi.org\/10.1016\/j.ijcard.2010.08.027","journal-title":"Int J Cardiol"},{"key":"1800_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1161\/circulationaha.107.747642","volume":"118","author":"H Thiele","year":"2008","unstructured":"Thiele H, Schindler K, Friedenberger J, Eitel I, Furnau G, Grebe E, Erbs S, Linke A, Mobius-Winkler S, Kivelitz D, Schuler G (2008) Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial. Circulation 118:49\u201357. https:\/\/doi.org\/10.1161\/circulationaha.107.747642","journal-title":"Circulation"},{"key":"1800_CR11","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/j.jacc.2013.01.048","volume":"61","author":"I Eitel","year":"2013","unstructured":"Eitel I, Wohrle J, Suenkel H, Meissner J, Kerber S, Lauer B, Pauschinger M, Birkemeyer R, Axthelm C, Zimmermann R, Neuhaus P, Brosteanu O, de Waha S, Desch S, Gutberlet M, Schuler G, Thiele H (2013) Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the AIDA STEMI trial. J Am Coll Cardiol 61:1447\u20131454. https:\/\/doi.org\/10.1016\/j.jacc.2013.01.048","journal-title":"J Am Coll Cardiol"},{"key":"1800_CR12","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/s0140-6736(11)61872-2","volume":"379","author":"H Thiele","year":"2012","unstructured":"Thiele H, Wohrle J, Hambrecht R, Rittger H, Birkemeyer R, Lauer B, Neuhaus P, Brosteanu O, Sick P, Wiemer M, Kerber S, Kleinertz K, Eitel I, Desch S, Schuler G (2012) Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial. Lancet 379:923\u2013931. https:\/\/doi.org\/10.1016\/s0140-6736(11)61872-2","journal-title":"Lancet"},{"key":"1800_CR13","doi-asserted-by":"publisher","first-page":"210","DOI":"10.4330\/wjc.v10.i11.210","volume":"10","author":"D Muser","year":"2018","unstructured":"Muser D, Castro SA, Santangeli P, Nucifora G (2018) Clinical applications of feature-tracking cardiac magnetic resonance imaging. World J Cardiol 10:210\u2013221. https:\/\/doi.org\/10.4330\/wjc.v10.i11.210","journal-title":"World J Cardiol"},{"key":"1800_CR14","doi-asserted-by":"publisher","first-page":"e005986","DOI":"10.1161\/circimaging.116.005986","volume":"10","author":"D Liu","year":"2017","unstructured":"Liu D, Borlotti A, Viliani D, Jerosch-Herold M, Alkhalil M, De Maria GL, Fahrni G, Dawkins S, Wijesurendra R, Francis J, Ferreira V, Piechnik S, Robson MD, Banning A, Choudhury R, Neubauer S, Channon K, Kharbanda R, Dall'Armellina E (2017) CMR native T1 mapping allows differentiation of reversible versus irreversible myocardial damage in ST-segment-elevation myocardial infarction: an OxAMI study (oxford acute myocardial infarction). Circ Cardiovasc Imaging 10:e005986. https:\/\/doi.org\/10.1161\/circimaging.116.005986","journal-title":"Circ Cardiovasc Imaging"},{"key":"1800_CR15","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ijcard.2018.05.082","volume":"15","author":"G Nucifora","year":"2018","unstructured":"Nucifora G, Muser D, Tioni C, Shah R, Selvanayagam J (2018) Prognostic value of myocardial deformation imaging by cardiac magnetic resonance feature-tracking in patients with a first ST-segment elevation myocardial infarction. Int J Cardiol 15:387\u2013391. https:\/\/doi.org\/10.1016\/j.ijcard.2018.05.082","journal-title":"Int J Cardiol"},{"key":"1800_CR16","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/j.jcmg.2017.11.034","volume":"11","author":"I Eitel","year":"2018","unstructured":"Eitel I, Stiermaier T, Lange T, Rommel KP, Koschalka A, Kowallick JT, Lotz J, Kutty S, Gutberlet M, Hasenfuss G, Thiele H, Schuster A (2018) Cardiac magnetic resonance myocardial feature tracking for optimized prediction of cardiovascular events following myocardial infarction. JACC Cardiovasc Imaging 11:1433\u20131444. https:\/\/doi.org\/10.1016\/j.jcmg.2017.11.034","journal-title":"JACC Cardiovasc Imaging"},{"key":"1800_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1532-429X-16-38","volume":"16","author":"JN Khan","year":"2014","unstructured":"Khan JN, Razvi N, Nazir SA, Singh A, Masca NG, Gershlick AH, Squire I, McCann GP (2014) Prevalence and extent of infarct and microvascular obstruction following different reperfusion therapies in ST-elevation myocardial infarction. J Cardiovasc Magn Resonanc 16:38. https:\/\/doi.org\/10.1186\/1532-429X-16-38","journal-title":"J Cardiovasc Magn Resonanc"},{"key":"1800_CR18","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1177\/0003319712474336","volume":"65","author":"G Galasso","year":"2014","unstructured":"Galasso G, Schiekofer S, D'Anna C, Gioia GD, Piccolo R, Niglio T, Rosa RD, Strisciuglio T, Cirillo P, Piscione F, Trimarco B (2014) No-reflow phenomenon: pathophysiology, diagnosis, prevention, and treatment*** A review of the current literature and future perspectives. Angiology 65:180\u2013189. https:\/\/doi.org\/10.1177\/0003319712474336","journal-title":"Angiology"},{"key":"1800_CR19","doi-asserted-by":"crossref","unstructured":"Niccoli G, Cosentino N, Minelli S, Cataneo L, Crea F 2013 Microvascular obstruction after primary percutaneous coronary intervention: pathogenesis, diagnosis and prognostic significance. Curr Vasc Pharmacol 11: 245\u201362, https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23506502","DOI":"10.2174\/1570161111311020013"},{"key":"1800_CR20","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1177\/0003319713514290","volume":"66","author":"J Zhu","year":"2015","unstructured":"Zhu J, Zhang T, Xie Q, Zhang J (2015) Effects of upstream administration of tirofiban before percutaneous coronary intervention on spontaneous reperfusion and clinical outcomes in acute ST-segment elevation myocardial infarction. Angiology 66:70\u201378. https:\/\/doi.org\/10.1177\/0003319713514290","journal-title":"Angiology"},{"key":"1800_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005208.pub3","author":"A Ciccone","year":"2014","unstructured":"Ciccone A, Motto C, Abraha I, Cozzolino F, Santilli I (2014) Glycoprotein IIb-IIIa inhibitors for acute ischaemic stroke. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD005208.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"1800_CR22","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/ccd.24653","volume":"82","author":"A Sethi","year":"2013","unstructured":"Sethi A, Bajaj A, Bahekar A, Bhuriya R, Singh M, Ahmed A, Khosla S (2013) Glycoprotein IIb\/IIIa inhibitors with or without thienopyridine pretreatment improve outcomes after primary percutaneous coronary intervention in high-risk patients with ST elevation myocardial infarction\u2013a meta-regression of randomized controlled trials. Catheter Cardiovasc Interv 82:171\u2013181. https:\/\/doi.org\/10.1002\/ccd.24653","journal-title":"Catheter Cardiovasc Interv"},{"key":"1800_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3969\/j.issn.1671-5411.2013.01.009","volume":"10","author":"X Liu","year":"2013","unstructured":"Liu X, Tao GZ (2013) Effects of tirofiban on the reperfusion-related no-reflow in rats with acute myocardial infarction. J Geriatr Cardiol 10:52\u201358. https:\/\/doi.org\/10.3969\/j.issn.1671-5411.2013.01.009","journal-title":"J Geriatr Cardiol"},{"key":"1800_CR24","doi-asserted-by":"crossref","unstructured":"Giordano A, Musumeci G, D'Angelillo A, Rossini R, Zoccai GB, Messina S, Coscioni E, Romano S, Romano MF 2016 Effects of glycoprotein IIb\/IIIa antagonists: anti platelet aggregation and beyond. Curr Drug Metab 17: 194\u2013203, https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26652157","DOI":"10.2174\/1389200217666151211121112"},{"key":"1800_CR25","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1161\/CIRCRESAHA.119.315344","volume":"125","author":"G Niccoli","year":"2019","unstructured":"Niccoli G, Montone RA, Ibanez B, Thiele H, Crea F, Heusch G, Bulluck H, Hausenloy DJ, Berry C, Stiermaier T, Camici PG, Eitel I (2019) Optimized treatment of ST-elevation myocardial infarction. Circ Res 125:245\u2013258. https:\/\/doi.org\/10.1161\/CIRCRESAHA.119.315344","journal-title":"Circ Res"},{"key":"1800_CR26","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1177\/0003319714545780","volume":"66","author":"M Akpek","year":"2015","unstructured":"Akpek M, Sahin O, Sarli B, Baktir AO, Saglam H, Urkmez S, Ergin A, Oguzhan A, Arinc H, Kaya MG (2015) Acute effects of intracoronary tirofiban on no-reflow phenomena in patients with ST-segment elevated myocardial infarction undergoing primary percutaneous coronary intervention. Angiology 66:560. https:\/\/doi.org\/10.1177\/0003319714545780","journal-title":"Angiology"},{"key":"1800_CR27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11239-012-0685-y","volume":"34","author":"B Candemir","year":"2012","unstructured":"Candemir B, Kilickap M, Ozcan OU, Kaya CT, Gerede M, Ozdemir AO, Ozdol C, Kumbasar D, Erol C (2012) Intracoronary versus intravenous high-dose bolus plus maintenance administration of tirofiban in patients undergoing primary percutaneous coronary intervention for acute ST elevation myocardial infarction. J Thromb Thrombol 34:65\u201372. https:\/\/doi.org\/10.1007\/s11239-012-0685-y","journal-title":"J Thromb Thrombol"},{"key":"1800_CR28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1148\/radiol.2015142674","volume":"278","author":"V Bodi","year":"2016","unstructured":"Bodi V, Monmeneu JV, Ortiz-Perez JT, Lopez-Lereu MP, Bonanad C, Husser O, Minana G, Gomez C, Nunez J, Forteza MJ, Hervas A, de Dios E, Moratal D, Bosch X, Chorro FJ (2016) Prediction of reverse remodeling at cardiac MR imaging soon after first ST-segment-elevation myocardial infarction: results of a large prospective registry. Radiology 278:54\u201363. https:\/\/doi.org\/10.1148\/radiol.2015142674","journal-title":"Radiology"},{"key":"1800_CR29","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.jcmg.2014.06.012","volume":"7","author":"YS Hamirani","year":"2014","unstructured":"Hamirani YS, Wong A, Kramer CM, Salerno M (2014) Effect of microvascular obstruction and intramyocardial hemorrhage by CMR on LV remodeling and outcomes after myocardial infarction: a systematic review and meta-analysis. JACC Cardiovasc Imaging 7:940\u2013952. https:\/\/doi.org\/10.1016\/j.jcmg.2014.06.012","journal-title":"JACC Cardiovasc Imaging"},{"key":"1800_CR30","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/jmri.25780","volume":"47","author":"L Zhang","year":"2018","unstructured":"Zhang L, Mandry D, Chen B, Huttin O, Hossu G, Wang H, Beaumont M, Girerd N, Felblinger J, Odille F (2018) Impact of microvascular obstruction on left ventricular local remodeling after reperfused myocardial infarction. J Magn Reson Imaging 47:499\u2013510. https:\/\/doi.org\/10.1002\/jmri.25780","journal-title":"J Magn Reson Imaging"},{"key":"1800_CR31","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1136\/hrt.2010.202028","volume":"97","author":"AN Mather","year":"2011","unstructured":"Mather AN, Fairbairn TA, Ball SG, Greenwood JP, Plein S (2011) Reperfusion haemorrhage as determined by cardiovascular MRI is a predictor of adverse left ventricular remodelling and markers of late arrhythmic risk. Heart 97:453\u2013459. https:\/\/doi.org\/10.1136\/hrt.2010.202028","journal-title":"Heart"},{"key":"1800_CR32","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/ccd.22157","volume":"74","author":"J Vicente","year":"2009","unstructured":"Vicente J, Mewton N, Croisille P, Staat P, Bonnefoy-Cudraz E, Ovize M, Revel D (2009) Comparison of the angiographic myocardial blush grade with delayed-enhanced cardiac magnetic resonance for the assessment of microvascular obstruction in acute myocardial infarctions. Catheter Cardiovasc Interv 74:1000\u20131007. https:\/\/doi.org\/10.1002\/ccd.22157","journal-title":"Catheter Cardiovasc Interv"},{"key":"1800_CR33","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.amjcard.2015.06.034","volume":"116","author":"M Regenfus","year":"2015","unstructured":"Regenfus M, Schlundt C, Kr\u00e4hner R, Sch\u00f6negger C, Adler W, Ludwig J, Daniel WG, Schmid M (2015) Six-year prognostic value of microvascular obstruction after reperfused ST-elevation myocardial infarction as assessed by contrast-enhanced cardiovascular magnetic resonance. Am J Cardiol 116:1022\u20131027. https:\/\/doi.org\/10.1016\/j.amjcard.2015.06.034","journal-title":"Am J Cardiol"},{"key":"1800_CR34","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.jcmg.2014.05.010","volume":"7","author":"M Van Kranenburg","year":"2014","unstructured":"Van Kranenburg M, Magro M, Thiele H, de Waha S, Eitel I, Cochet A, Cottin Y, Atar D, Buser P, Wu E (2014) Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients. JACC 7:930\u2013939. https:\/\/doi.org\/10.1016\/j.jcmg.2014.05.010","journal-title":"JACC"},{"key":"1800_CR35","doi-asserted-by":"publisher","first-page":"52","DOI":"10.4103\/2211-4122.135615","volume":"24","author":"G Novo","year":"2014","unstructured":"Novo G, Sutera MR, Lisi DD, Galifi MA, Fata B, Giambanco S, Arvigo L, Triolo OF, Evola S, Assennato P, Novo S (2014) Assessment of no-reflow phenomenon by myocardial blush grade and pulsed wave tissue doppler imaging in patients with acute coronary syndrome. J Cardiovasc Echogr 24:52\u201356. https:\/\/doi.org\/10.4103\/2211-4122.135615","journal-title":"J Cardiovasc Echogr"},{"key":"1800_CR36","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.amjcard.2013.03.011","volume":"112","author":"E Buyukkaya","year":"2013","unstructured":"Buyukkaya E, Poyraz F, Karakas MF, Kurt M, Akcay AB, Akpinar I, Motor S, Turak O, Ozturk OH, Sen N, Akpek M, Kaya MG, Gibson CM (2013) Usefulness of monocyte chemoattractant protein-1 to predict no-reflow and three-year mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol 112:187\u2013193. https:\/\/doi.org\/10.1016\/j.amjcard.2013.03.011","journal-title":"Am J Cardiol"},{"key":"1800_CR37","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1161\/CIRCULATIONAHA.110.002741","volume":"122","author":"YL Gu","year":"2010","unstructured":"Gu YL, Kampinga MA, Wieringa WG, Fokkema ML, Nijsten MW, Hillege HL, van den Heuvel AF, Tan ES, Pundziute G, van der Werf R, Hoseyni Guyomi S, van der Horst IC, Zijlstra F, de Smet BJ (2010) Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial. Circulation 122:2709\u20132717. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.002741","journal-title":"Circulation"},{"key":"1800_CR38","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1016\/j.amjcard.2010.01.006","volume":"105","author":"OF Bertrand","year":"2010","unstructured":"Bertrand OF, Rodes-Cabau J, Larose E, Rinfret S, Gaudreault V, Proulx G, Barbeau G, Dery JP, Gleeton O, Manh-Nguyen C, Noel B, Roy L, Costerousse O, De Larochelliere R, Investigators EADaTSoCAiAMIS (2010) Intracoronary compared to intravenous Abciximab and high-dose bolus compared to standard dose in patients with ST-segment elevation myocardial infarction undergoing transradial primary percutaneous coronary intervention: a two-by-two factorial placebo-controlled randomized study. Am J Cardiol 105:1520\u20131527. https:\/\/doi.org\/10.1016\/j.amjcard.2010.01.006","journal-title":"Am J Cardiol"},{"key":"1800_CR39","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1540-8183.2010.00616.x","volume":"24","author":"A Iversen","year":"2011","unstructured":"Iversen A, Abildgaard U, Galloe A, Hansen PR, Galatius S, Madsen JK, Engstroem T, Pedersen S, Jensen KS, Jensen JS (2011) Intracoronary compared to intravenous bolus abciximab during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction (STEMI) patients reduces 30-day mortality and target vessel revascularization: a randomized trial. J Intervent Cardiol 24:105\u2013111. https:\/\/doi.org\/10.1111\/j.1540-8183.2010.00616.x","journal-title":"J Intervent Cardiol"},{"key":"1800_CR40","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5174714","author":"JH Wu","year":"2018","unstructured":"Wu JH, Hao PP, Chen YG, Li RJ (2018) Intracoronary glycoprotein IIb\/IIIa inhibitors improve short-term mortality and reinfarction in East Asian patients with ST-segment elevation myocardial infarction after thrombus aspiration: a meta-analysis. ECAM. https:\/\/doi.org\/10.1155\/2018\/5174714","journal-title":"ECAM"},{"key":"1800_CR41","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s11886-017-0907-1","volume":"19","author":"G Pontone","year":"2017","unstructured":"Pontone G, Carita P, Rabbat MG, Guglielmo M, Baggiano A, Muscogiuri G, Guaricci AI (2017) Role of Cardiac Magnetic Resonance Imaging in Myocardial Infarction. Curr Cardiol Rep 19:101. https:\/\/doi.org\/10.1007\/s11886-017-0907-1","journal-title":"Curr Cardiol Rep"},{"key":"1800_CR42","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1016\/j.jcmg.2017.10.014","volume":"11","author":"P Kellman","year":"2018","unstructured":"Kellman P (2018) Dark-blood late-enhancement imaging improves detection of myocardial infarction. JACC Cardiovasc Imaging 11:1770\u20131772. https:\/\/doi.org\/10.1016\/j.jcmg.2017.10.014","journal-title":"JACC Cardiovasc Imaging"},{"key":"1800_CR43","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12968-017-0407-x","volume":"19","author":"R Francis","year":"2017","unstructured":"Francis R, Kellman P, Kotecha T, Baggiano A, Norrington K, Martinez-Naharro A, Nordin S, Knight DS, Rakhit RD, Lockie T, Hawkins PN, Moon JC, Hausenloy DJ, Xue H, Hansen MS, Fontana M (2017) Prospective comparison of novel dark blood late gadolinium enhancement with conventional bright blood imaging for the detection of scar. J Cardiovasc Magn Resonanc 19:91. https:\/\/doi.org\/10.1186\/s12968-017-0407-x","journal-title":"J Cardiovasc Magn Resonanc"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-020-01800-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10554-020-01800-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-020-01800-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T19:38:06Z","timestamp":1613763486000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10554-020-01800-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,20]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["1800"],"URL":"https:\/\/doi.org\/10.1007\/s10554-020-01800-0","relation":{},"ISSN":["1569-5794","1573-0743"],"issn-type":[{"value":"1569-5794","type":"print"},{"value":"1573-0743","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,20]]},"assertion":[{"value":"30 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}